TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Office of Translational Research


Welcome to the NINDS Office of Translational Research (OTR). Our mission is to accelerate the preclinical discovery and development of new therapeutic interventions for neurological disorders. To facilitate this process, OTR offers a variety of funding opportunities and programs. Researchers looking for funding should click on the Funding and Programs for Researchers tab, which shows programs based on the type of therapeutic approach and stage of project they support. Investigators and potential investors interested in our active grant portfolio or in partnering should click on the Active Projects for Partnering tab. Are you new to translational research? If so, click on the decision tree for therapeutic development to explore funding opportunity pathways.

  • carousel_create-imagemap
  • SBIR/STTR Success Stories
  • carousel blueprint banner
  • carousel counteract banner
  • carousel small business banner
  • Innovation Grants to Nurture Initial Translational Efforts
  • banner controller


OTR Updates

Dr. Alan Willard has agreed to serve as the Acting Director of the Office of Translational Research after the departure of Dr. Ranganathan.

Watch Former OTR Director Rajesh Ranganathan's talk at the 10th Annual Non-Dilutive Funding Summit in San Francisco, CA.



Are you developing a small molecule
Are you developing a biologic
Are you developing a therapeutic device

Plus/Minus Sign   

Office of Translational Research Program Staff

Karrah Benson, B.S.
Program Coordinator
Anticonvulsant Screening Program (ASP)

Chris Boshoff, Ph.D.
Scientific Project Manager
Cooperative Program in Translational Research and CREATE Bio

Charles Cywin, Ph.D.
Project Manager
Blueprint Neurotherapeutics Network

Stephanie Fertig, MBA
Director, Small Business Programs
Small business (SBIR, STTR) and CREATE Devices

David Jett, Ph.D.
Program Director
Countermeasures (CounterACT) Programs, Neurotoxicology, Roadmap Molecular Libraries

John Kehne, Ph.D.
Program Director
Anticonvulsant Screening Program (ASP)

Pascal Laeng, Ph.D.
Scientific Project Manager
Blueprint Neurotherapeutics Network

Linda McGavern, Ph.D.
Project Manager
Cooperative Program in Translational Research and CREATE Bio

Mary Ann Pelleymounter, Ph.D.
Program Director
Blueprint Neurotherapeutics Program, IGNITE Program

Shamsi Raeissi, Ph.D.
Scientific Project Manager
Anticonvulsant Screening Program (ASP)

Rebecca Roof, Ph.D.
Health Program Specialist
Small Business (SBIR, STTR), IGNITE Program

Brian Klein, Ph.D.
Program Manager
Anticonvulsant Screening Program (ASP)

Amir Tamiz, Ph.D.
Program Director
Blueprint Neurotherapeutics Program, IGNITE Program (Lead)

Christina Vert, M.S.
Health Program Specialist
Cooperative Program in Translational Research and CREATE Bio

Hao Wang, Ph.D.
Program Director
Cooperative Program in Translational Research and CREATE Bio

Derek Wilkinson, Ph.D.
Health Program Specialist
Blueprint Neurotherapeutics Network

Alan Willard, Ph.D.
Acting Director, Office of Translational Research (OTR)

David Yeung, Ph.D.
Scientific Project Manager
Countermeasures Against Chemical Threats(CounterACT) Programs